XOMAP FY 2016 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$309M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-90.0% YoY

Gross Profit

$4M74.8% margin

Operating Income

-$62M-1106.4% margin

Net Income

-$54M-962.1% margin

EPS (Diluted)

$-4.72

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$29M

Total Liabilities

$76M

Stockholders' Equity

-$47M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$55M	-90.0%
Gross Profit	$4M	$35M	-88.0%
Operating Income	-$62M	-$40M	-55.0%
Net Income	-$54M	-$21M	-159.8%